Homocysteine-lowering B vitamins do not lower mortality or cardiovascular events.
Lundberg
George D
GD
The Medscape Journal of Medicine, Stanford University School of Medicine, Stanford, California, USA. glundberg@medscape.net
D000368:Aged; D001024:Aortic Valve Stenosis / Q000097:blood* / Q000517:prevention & control*; D002318:Cardiovascular Diseases / Q000097:blood / Q000401:mortality; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000097:blood* / Q000517:prevention & control*; D004311:Double-Blind Method; D005260:Female; D005492:Folic Acid / Q000097:blood / Q000627:therapeutic use; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D016019:Survival Analysis; D015996:Survival Rate; D014805:Vitamin B 12 / Q000008:administration & dosage* / Q000097:blood; D025101:Vitamin B 6 / Q000008:administration & dosage* / Q000097:blood; D014803:Vitamin B Complex / Q000097:blood
D006710:Homocysteine; D014803:Vitamin B Complex; D025101:Vitamin B 6; D005492:Folic Acid; D014805:Vitamin B 12